Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 384, pseudogene (RNU6-384P)** is a human pseudogene related to U6 small nuclear RNA (snRNA) family. U6 snRNA itself is a highly conserved, non-coding RNA that is a core component of the major spliceosome complex involved in pre-mRNA splicing, where it plays a critical structural and catalytic role[1][2]. However, *RNU6-384P* is one of many genomic loci annotated as *pseudogenes* for U6 snRNA, found throughout mammalian genomes, including in humans[2][3]. Pseudogenes, by definition, are genomic DNA sequences similar to known genes but are non-functional due to mutations or truncations that prevent normal expression or function[3]. There is no evidence that RNU6-384P is transcribed or functions as a protein or regulatory RNA. There is also no evidence in the scientific literature or clinical resources that this pseudogene serves as a therapeutic target, a disease biomarker, or is associated with a drug mechanism of action. Its "pseudogene" status means it should not be considered a target for therapeutic intervention, and it has no established physiological, pathological, or therapeutic relevance. If the intent was to refer to U6 small nuclear RNA (snRNA) itself, that is a distinct, functional molecule and a core part of the RNA splicing apparatus[1][2]; the pseudogene is non-functional and not a biologically relevant target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 384, pseudogene (RNU6-384P).